Translate the page
Like this video

EpigenCare

Truly Personalized Skincare Based on Epigenetics

EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin's epigenetic profiles. A reward mechanism is implemented to encourage recurring tests and create transaction records on the blockchain ledger. This tokenization of data allows consumers to verify that their data is used solely for their own benefit in the structured ecosystem, solving the problem of perceived instrusiveness associated with personal tests requiring consumer DNA.

3.4
2 1 expert rating
Benchy 3.5
Experts
4.0
3.0
2.0
View rating distribution
~$36,701
value of tokens sold in ICO
Ended
Token
EPIC
Price in ICO
0.4000 USD
Country
USA
Whitelist/KYC
KYC
Restricted areas
China
preICO start
19th Mar 2018
preICO end
15th Apr 2018
ICO start
16th Apr 2018
ICO end
31st Jul 2018
More on ICO
Report

About EpigenCare

Scientifically Grounded

How does a consumer know whether a skincare product is truly working for them? EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them.

 

A Cyclical Growth Ecosystem

As epigenetics regulates gene function and dynamically changes based on environment stimuli such as skincare product ingredients, it is a perfect fit for a recurring, tokenized business model. EpigenCare’s upcoming platform will be a structured ecosystem that allows skincare companies to target data segments with products that fulfill the recommendation engine’s matching requirements. Consumers that fall within the segment are rewarded with tokens, which can be used to subsidize additional tests (thereby generating additional advertising inventory for companies).

 

Disrupting the Skincare Industry

Our structured ecosystem allows for true leveraging of blockchain technology. The recurring nature of epigenetics allows for a perpetual incentivization model through data tokenization. By associating a transaction hash ID with each purchased test and data segment, we will be able to transparently prove that a consumer’s data is used only for their own benefit, thereby addressing the problem of perceived intrusiveness often associated with commercialized DNA-related testing. EpigenCare’s disruptive innovation introduces a new marketing channel to the $130 billion skincare industry and transform the way companies market their products to consumers through scientifically screened, individualized advertising.

 

Bookmark
ICO KYC Report
2 members invited
William Lee
Passed
Jessica Li
Passed
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

Viaz

The utility of VIAZ is to provide a decentralized funding platform, connecting its user...

Starts in 58 days 13 hours

Volentix

Volentix is building a decentralized digital assets exchange connected with a secure mu...

44 days 13 hours left

Somesing

SOMESING is a social music service that incorporates blockchain technology so that prod...

Starts in 54 days 13 hours
4.6

Worldopo

Become a Cryptolord in the the world’s first mobile game that combine Augmented Reali...

61 days 12 hours left
ICO Market Report - November 2018ICO Market Report - November 2018

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it